Clinical study on efficacy and safety of Huangqi Guizhi Wuwu decoction bubble bag in paclitaxel related peripheral neuritis of breast cancer patients : A protocol for a randomized, controlled, double-blind trial
- Conditions
- Breast Cancer
- Registration Number
- ITMCTR2200006006
- Lead Sponsor
- ational Cancer Center, Chinese Academy of Medical Sciences / Cancer Hospital of Peking Union Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
????????????????;???18-70?;???????????????????:????????,?????,??????,??????;???????3????;?????????????;???????,???????
????????????????;???18-70?;???????????????????:????????,?????,??????,??????;???????3????;?????????????;???????,???????
(1) breast cancer patients confirmed by histology or pathology; ? Age 18-70 years old; ? Plan to receive or have received paclitaxel drugs: including solvent paclitaxel, docetaxel, albumin paclitaxel, paclitaxel liposome; ? The estimated survival time is more than 3 months; ? It conforms to the category of syndrome differentiation and treatment of blood arthralgia in traditional Chinese medicine; The patient is unconscious and can communicate with normal language
? Age < 18 years old, > 70 years old; ? Peripheral neuropathy caused by other reasons; ? There are heart, liver and kidney insufficiency, cardiovascular disease and endocrine disease; Accompanied by mental and consciousness disorders; Severe skin disease and systemic infection; ? The patient was involuntary.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation scale of peripheral neurotoxicity of chemotherapeutic drugs (EORTC qlq-cipn20);Mental state rating scale;Score of TCM syndrome integral quantitative scale (slefi);
- Secondary Outcome Measures
Name Time Method